Who owns 032420901 - ANACOR PHARMACEUTICALS INC - COM - Call based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

ANACOR PHARMACEUTICALS INC - COM - Call Institutional Ownership

Q: What is CUSIP 032420901?

CUSIP 032420901 is the security identifier used in SEC filing datasets for 032420901 - ANACOR PHARMACEUTICALS INC - COM - Call.

CUSIP: 032420901

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2016

Type / Class: Equity / COM

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 032420901?
CUSIP 032420901 identifies 032420901 - ANACOR PHARMACEUTICALS INC - COM - Call in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 032420901:

Q3 2016 (0 holders) Q2 2016 (0 holders) Q1 2016 (0 holders) Q4 2015 (0 holders) Q3 2015 (0 holders) Q2 2015 (0 holders) Q1 2015 (0 holders) Q4 2014 (0 holders) Q3 2014 (0 holders) Q2 2014 (0 holders)

Institutional Holders of ANACOR PHARMACEUTICALS INC - COM - Call across Reporting Periods

Period	Calls Notional Value	Price (Median)
2016 Q3	$0
2016 Q2	$14,000	$5.13
2016 Q1	$25,595,000	$53.45
2015 Q4	$16,053,000	$451.23
2015 Q3	$8,673,000	$3025.88
2015 Q2	$14,109,000	$927.25
2015 Q1	$6,745,000	$57.85
2014 Q4	$2,326,000	$32.25
2014 Q3	$1,554,000	$24.47
2014 Q2	$243,000	$17.74
2014 Q1	$752,000	$20.00